Candidiasis, Vulvovaginal
"Candidiasis, Vulvovaginal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Infection of the VULVA and VAGINA with a fungus of the genus CANDIDA.
| Descriptor ID |
D002181
|
| MeSH Number(s) |
C01.703.160.190 C13.351.500.894.906.820.500 C13.351.500.944.902.737.500
|
| Concept/Terms |
Candidiasis, Vulvovaginal- Candidiasis, Vulvovaginal
- Vulvovaginal Candidiases
- Vulvovaginal Candidiasis
- Moniliasis, Vulvovaginal
- Vulvovaginal Moniliases
- Vulvovaginal Moniliasis
- Vaginal Yeast Infections
- Infection, Vaginal Yeast
- Infections, Vaginal Yeast
- Yeast Infection, Vaginal
- Yeast Infections, Vaginal
- Vaginal Yeast Infection
- Genital Vulvovaginal Candidiasis
- Candidiases, Genital Vulvovaginal
- Candidiasis, Genital Vulvovaginal
- Genital Vulvovaginal Candidiases
- Vulvovaginal Candidiases, Genital
- Vulvovaginal Candidiasis, Genital
- Candidiasis, Genital
- Candidiases, Genital
- Genital Candidiases
- Genital Candidiasis
Vaginitis, Monilial- Vaginitis, Monilial
- Monilial Vaginitides
- Monilial Vaginitis
- Vaginitides, Monilial
|
Below are MeSH descriptors whose meaning is more general than "Candidiasis, Vulvovaginal".
Below are MeSH descriptors whose meaning is more specific than "Candidiasis, Vulvovaginal".
This graph shows the total number of publications written about "Candidiasis, Vulvovaginal" by people in this website by year, and whether "Candidiasis, Vulvovaginal" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1998 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2008 | 2 | 1 | 3 |
| 2009 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 0 | 2 | 2 |
| 2018 | 4 | 0 | 4 |
| 2019 | 2 | 0 | 2 |
| 2020 | 2 | 0 | 2 |
| 2021 | 3 | 0 | 3 |
| 2022 | 5 | 0 | 5 |
| 2023 | 1 | 0 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Candidiasis, Vulvovaginal" by people in Profiles.
-
Schwebke JR, Nyirjesy P, Dsouza M, Getman D. Vaginitis and risk of sexually transmitted infections: results of a multi-center U.S. clinical study using STI nucleic acid amplification testing. J Clin Microbiol. 2024 Sep 11; 62(9):e0081624.
-
File B, Sobel R, Becker M, Nyirjesy P. Fluconazole-Resistant Candida albicans Vaginal Infections at a Referral Center and Treated With Boric Acid. J Low Genit Tract Dis. 2023 Jul 01; 27(3):262-265.
-
Shroff S. Infectious Vaginitis, Cervicitis, and Pelvic Inflammatory Disease. Med Clin North Am. 2023 Mar; 107(2):299-315.
-
Goje O, Sobel R, Nyirjesy P, Goldstein SR, Spitzer M, Faught B, Larson S, King T, Azie NE, Angulo D, Sobel JD. Oral Ibrexafungerp for Vulvovaginal Candidiasis Treatment: An Analysis of VANISH 303 and VANISH 306. J Womens Health (Larchmt). 2023 02; 32(2):178-186.
-
Nyirjesy P, Schwebke JR, Angulo DA, Harriott IA, Azie NE, Sobel JD. Phase 2 Randomized Study of Oral Ibrexafungerp Versus Fluconazole in Vulvovaginal Candidiasis. Clin Infect Dis. 2022 07 06; 74(12):2129-2135.
-
Schwebke JR, Sobel R, Gersten JK, Sussman SA, Lederman SN, Jacobs MA, Chappell BT, Weinstein DL, Moffett AH, Azie NE, Angulo DA, Harriott IA, Borroto-Esoda K, Ghannoum MA, Nyirjesy P, Sobel JD. Ibrexafungerp Versus Placebo for Vulvovaginal Candidiasis Treatment: A Phase 3, Randomized, Controlled Superiority Trial (VANISH 303). Clin Infect Dis. 2022 06 10; 74(11):1979-1985.
-
Nyirjesy P, Brookhart C, Lazenby G, Schwebke J, Sobel JD. Vulvovaginal Candidiasis: A Review of the Evidence for the 2021 Centers for Disease Control and Prevention of Sexually Transmitted Infections Treatment Guidelines. Clin Infect Dis. 2022 04 13; 74(Suppl_2):S162-S168.
-
Sobel JD, Nyirjesy P. Oteseconazole: an advance in treatment of recurrent vulvovaginal candidiasis. Future Microbiol. 2021 12; 16:1453-1461.
-
Sobel R, Nyirjesy P, Ghannoum MA, Delchev DA, Azie NE, Angulo D, Harriott IA, Borroto-Esoda K, Sobel JD. Efficacy and safety of oral ibrexafungerp for the treatment of acute vulvovaginal candidiasis: a?global phase 3, randomised, placebo-controlled superiority study (VANISH 306). BJOG. 2022 02; 129(3):412-420.
-
Brand SR, Sobel JD, Nyirjesy P, Ghannoum MA, Schotzinger RJ, Degenhardt TP. A Randomized Phase 2 Study of VT-1161 for the Treatment of Acute Vulvovaginal Candidiasis. Clin Infect Dis. 2021 10 05; 73(7):e1518-e1524.